SUSQUEHANNA INTERNATIONAL GROUP, LLP - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 66 filers reported holding IMMUNE DESIGN CORP in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q1 2019$74,000
+64.4%
12,600
-64.3%
0.00%
Q4 2018$45,000
-74.7%
35,287
-31.6%
0.00%
Q3 2018$178,000
-48.7%
51,600
-32.3%
0.00%
Q2 2018$347,000
+59.2%
76,200
+15.2%
0.00%
Q1 2018$218,000
+15.3%
66,154
+36.3%
0.00%
Q4 2017$189,000
-31.8%
48,532
+81.1%
0.00%
Q3 2017$277,000
-65.3%
26,800
-77.2%
0.00%
Q1 2017$799,000
+496.3%
117,519
+383.3%
0.00%
Q4 2016$134,000
+2.3%
24,318
+140.8%
0.00%
Q1 2016$131,00010,1000.00%
Other shareholders
IMMUNE DESIGN CORP shareholders Q4 2016
NameSharesValueWeighting ↓
ProQuest Associates IV LLC 1,236,394$4,080,0004.69%
Versant Venture Management, LLC 2,208,210$7,287,093,0002.33%
EcoR1 Capital, LLC 4,437,600$14,422,0001.45%
BVF INC/IL 4,106,200$13,550,0001.37%
Abingworth LLP 352,300$1,145,0000.71%
DAFNA Capital Management LLC 328,500$1,084,0000.53%
Bain Capital Public Equity Management, LLC 1,680,987$5,547,0000.40%
Telemetry Investments, L.L.C. 248,800$821,0000.31%
Stonepine Capital Management, LLC 161,226$532,0000.28%
Focused Wealth Management, Inc 12,395$41,0000.01%
View complete list of IMMUNE DESIGN CORP shareholders